LOGIN  |  REGISTER
Chimerix
Chimerix

LevelJump Healthcare Announces New Teleradiology Contract in Saskatchewan

September 25, 2023 | Last Trade: C$0.05 0.00 0.00

Toronto, Ontario--(Newsfile Corp. - September 25, 2023) - LevelJump Healthcare Corp. (TSXV: JUMP) (OTCQB: JMPHF) (FSE: 75J) ("LevelJump" or the "Company"), a Canadian leader in B2B telehealth solutions, is pleased to announce that its' wholly owned subsidiary, Canadian Teleradiology Services ("CTS") has entered a new contract to provide teleradiology services.

CTS is expanding its services beyond Ontario to provide remote radiology readings to Circle West Ultrasound Diagnostics and Warman Medical Imaging, both located in Saskatoon, Saskatchewan. The workload includes daytime readings for Ultrasound patients.

This new contract exemplifies the Company's ongoing growth and commitment to expanding its Teleradiology partnerships across the country. The CTS solution plays a pivotal role in supporting hospitals and clinics in delivering round-the-clock radiology solutions, solidifying our commitment to expanding critical care for all.

"CTS is a leader in the Canadian telehealth space with a proven model, and we are thrilled to extend these much-needed services beyond Ontario," said Mitch Geisler, CEO. "We are excited to work with the Circle West team and continue working with underserviced communities providing urgent healthcare services to Canadians."

"We are thrilled to partner with CTS, to have a Canadian leader for radiology reporting solutions for our Ultrasound patients and elevate the overall healthcare experience at our clinics," said Terra Libke, President of Circle West and Warman Medical. "This partnership is particularly significant as it comes at a time when the demand for diagnostic imaging is soaring, and staffing shortages pose significant challenges."

About LevelJump Healthcare

LevelJump Healthcare Corp., (TSXV: JUMP) provides telehealth solutions to client hospitals and imaging centers through its Teleradiology division, as well as in person radiology services through its IHF's (Independent Healthcare Facilities). JUMP focuses primarily on critical care for urgent and emergency patients, establishing integral relationships in the communities we serve.

ON BEHALF OF THE BOARD OF DIRECTORS OF
LEVELJUMP HEALTHCARE CORP.

Mitchell Geisler
Chief Executive Officer

Caitlin-Robyn Densmore
Investor Relations Manager
This email address is being protected from spambots. You need JavaScript enabled to view it.
(437) 214-1568

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION

This news release contains "forward-looking information" within the meaning of applicable securities laws relating to the Company's business plans and the outlook of the Company's industry. Although the Company believes, in light of the experience of its officers and directors, current conditions and expected future developments and other factors that have been considered appropriate, that the expectations reflected in this forward-looking information are reasonable, undue reliance should not be placed on them because the Company can give no assurance that they will prove to be correct. Actual results and developments may differ materially from those contemplated by these statements. The statements in this press release are made as of the date of this release and the Company assumes no responsibility to update them or revise them to reflect new events or circumstances other than as required by applicable securities laws. The Company undertakes no obligation to comment on analyses, expectations or statements made by third-parties in respect of the Company, Canadian Teleradiology Services, Inc., their securities, or their respective financial or operating results (as applicable).

Neither the Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Exchange) accepts responsibility for the adequacy or accuracy of this release.

The securities being offered have not been, and will not be, registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act") or any U.S. state securities laws, and may not be offered or sold in the United States or to, or for the account or benefit of, United States persons absent registration or an applicable exemption from the registration requirements of the U.S. Securities Act and applicable U.S. state securities laws. This press release does not constitute an offer to sell or the solicitation of an offer to buy securities in the United States, nor in any other jurisdiction.

Terns Pharmaceuticals

Stock Quote

Featured Stock

Cue Biopharma

Cue Biopharma is developing the first-ever class of therapeutics for the treatment of cancer that mimic the natural signals, or “Cues”, of the immune system. This novel class of injectable biologics selectively engages and modulates tumor-specific T cells directly within the patient’s body to transform...

CLICK TO LEARN MORE

Featured Stock

Compass Therapeutics

Compass Therapeutics is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page

COPYRIGHT ©2023 HEALTH STOCKS HUB